Improved outcome in higher-risk acute lymphoblastic leukemia with a hybrid (Berlin-Frankfurt-Munster/St. Jude's) therapy

International Journal of Pediatric Hematology/Oncology

Volumn 3, Issue 6, 1996, Pages 439-449

  Sackmann Muriel, F ^a   Felice, M S ^a   Zubizarreta, P ^a   Chantada, G ^a   Fernandez Barbieri, M A ^a   Rossi, J ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Acute lymphoblastic leukemia; Continuation therapy; Higher risk; Lower risk

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; FEVER; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; IMMUNOPHENOTYPING; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKULL IRRADIATION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030481609     PISSN: 10702903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)